CureValue

About the offering

CureValue is a digital platform connecting Americans to trusted global healthcare options through AI-powered guidance, aiming to disrupt the medical tourism industry with transparency and technology. The Problem America's healthcare crisis has reached a breaking point, driving 2 million Americans abroad annually seeking affordable, high-quality care. Despite the $10 billion market opportunity, the medical tourism experience remains fragmented, overwhelming, and lacks trusted U.S.-focused platforms. Archaic systems slow innovation, trust remains the missing link, and technology hasn't scaled with market growth. The Solution CureValue provides end-to-end infrastructure for global healthcare access through a web platform (available at curevalue.org) with mobile apps launching November 2025. The platform offers treatment search by condition, procedure, or specialty; destination exploration with cost comparisons to U.S. treatment; facility ratings and patient feedback; contextual AI providing personalized recommendations; consultation with CureValue agents for custom quotes; and travel arrangement assistance. Business Model CureValue operates a multi-stream revenue model combining booking commissions (10-15%), subscription services (offering priority tools and calculators), and partnership revenue from providers and travel partners paying for exposure and bundled packages. Focusing on five high-demand treatments representing 60% of global medical tourism, the company targets $30-120 million in annual revenue from capturing just 1-2% market share. Traction Early results include 70% average cost savings based on patient bookings, growing partnerships with hospitals, insurers, and travel insurance providers (including Custom Assurance), and patients traveling for treatments in Mexico, France, Thailand, Albania, and other destinations. Early bookings are underway. Target Market The platform targets 35-65 year old Americans seeking affordable, high-quality care, including patients with high-deductible insurance plans, seniors impacted by potential Medicare cuts, and young professionals seeking elective procedures. CureValue focuses on five primary treatments in five primary destinations representing over 60% of medical tourism cases. Competition CureValue positions itself as exceeding competitors through technology and simplicity, offering dozens of treatments with transparent pricing and verified global care, powered by AI throughout the patient journey. Team Founder and CEO Farooq Zama brings 25 years in digital transformation across U.S. IT and healthcare industries. He serves as President of Autowoven, an enterprise consulting firm serving Fortune 500 healthcare clients, with expertise in building scalable, patient-centered platforms and AI-driven digital experiences. He also serves on the board of a nonprofit focused on equity, inclusion, and community impact. Darin Swinth serves as Partner for Global Operations. Current Fundraise CureValue is raising $500,000 at a $5 million valuation. Use of Funds The allocation breaks down as 30% for team expansion (hiring agents in Costa Rica, Mexico, and Thailand), 30% for marketing and growth (paid campaigns and SEO for U.S. audience), 20% for feature development (virtual consultations, mobile app, advanced AI features), and 20% for operations (platform infrastructure and support teams). Milestones Target milestones include expanding to 500 bookings by end of Year 1, achieving 1% market share by Year 3, and growing to 10,000 monthly users.

FAQ